NANTHEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5922 USD | +44.44% |
|
+53.06% | +37.72% |
| 04-23 | NantHealth, Inc. Announces the Appointment of Marc Harrison as Chief Legal Officer | CI |
| 04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
| Sales 2021 | 62.65M 5.02B | Sales 2022 | 67M 5.36B | Capitalization | 28.12M 2.25B |
|---|---|---|---|---|---|
| Net income 2021 | -58M -4.64B | Net income 2022 | -67M -5.36B | EV / Sales 2021 | 5.61 x |
| Net Debt 2021 | 229M 18.36B | Net Debt 2022 | 266M 21.27B | EV / Sales 2022 | 4.38 x |
| P/E ratio 2021 |
-2.07
x | P/E ratio 2022 |
-0.41
x | Employees | 373 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 11.69% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +44.44% | ||
| 1 week | +53.06% | ||
| Current month | +47.31% | ||
| 1 month | +51.23% | ||
| 3 months | +48.05% | ||
| 6 months | +48.05% | ||
| Current year | +37.72% |
1 week
0.38
0.60
1 month
0.340.74
Current year
0.250.74
1 year
0.203.79
3 years
0.2043.05
5 years
0.2099.00
10 years
0.20315.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 71 | 30/06/10 | |
R. Naseem
CEO | Chief Executive Officer | 57 | 06/09/23 |
Bob Petrou
DFI | Director of Finance/CFO | 52 | 11/09/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 71 | 30/06/10 | |
Kirk Calhoun
BRD | Director/Board Member | 80 | 30/04/16 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 30/06/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.5922 | +44.44% | 12,211 |
| 25/04/24 | 0.41 | -31.67% | 145 |
| 24/04/24 | 0.6 | +57.48% | 2,317 |
| 23/04/24 | 0.381 | -1.52% | 225 |
| 19/04/24 | 0.3869 | +13.46% | 788 |
Delayed Quote OTC Markets, April 26, 2024 at 08:31 pm
More quotes
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Companyâs products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Companyâs subsidiary, helps businesses monitor and manage network health and performance.
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +37.72% | 19.31M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -0.13% | 893M | |
| -35.42% | 902M | |
| -24.12% | 857M |
- Stock Market
- Equities
- NHIQ Stock
